TY - JOUR
T1 - The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis
AU - Valdes, Ana
AU - Wilde, Gert
AU - Doherty, Sally
AU - Lories, Rik
AU - Vaughn, Frances
AU - Laslett, Laura
AU - Maciewicz, Rose
AU - Soni, Anushka
AU - Hart, Deborah
AU - Zhang, Weiya
AU - Muir, Kenneth
AU - Dennison, Elaine
AU - Wheeler, Margaret
AU - Leaverton, Paul
AU - Cooper, Cyrus
AU - Spector, Timothy
AU - Cicuttini, Flavia
AU - Chapman, Victoria
AU - Jones, Graeme
AU - Arden, Nigel
AU - Doherty, Michael
PY - 2011
Y1 - 2011
N2 - Objective To assess if a coding variant in the gene encoding transient receptor potential cation channel, subfamily V, member 1 ( TRPV1 ) is associated with
genetic risk of painful knee osteoarthritis (OA).
Methods The Ile585Val TRPV1 variant encoded by
rs8065080 was genotyped in 3270 cases of symptomatic
knee OA, 1098 cases of asymptomatic knee OA and
3852 controls from seven cohorts from the UK, the USA
and Australia. The genetic association between the
low-pain genotype Ilea??Ile and risk of symptomatic and
asymptomatic knee OA was assessed.
Results The TRPV1 585 Ilea??Ile genotype, reported to
be associated with lower thermal pain sensitivity, was
associated with a lower risk of symptomatic knee OA
in a comparison of symptomatic cases with healthy
controls, with an odds ratio (OR) of 0.75 (95 CI 0.64
to 0.88; p=0.00039 by meta-analysis) after adjustment
for age, sex and body mass index. No difference was
seen between asymptomatic OA cases and controls
(OR=1.02, 95 CI 0.82 to 1.27 p=0.86) but the Ilea??Ile
genotype was associated with lower risk of symptomatic
versus asymptomatic knee OA adjusting for covariates
and radiographic severity (OR=0.73, 95 CI 0.57 to 0.94
p=0.0136). TRPV1 expression in articular cartilage was
increased by infl ammatory cytokines (tumour necrosis
factor I? and interleukin 1). However, there were no
differences in TRPV1 expression in healthy and arthritic
synovial tissue.
Conclusions A genotype involved in lower peripheral
pain sensitivity is signifi cantly associated with a
decreased risk of painful knee OA. This indicates a role for
the pro-nociceptive gene TRPV1 in genetic susceptibility
to symptomatic knee OA, which may also be infl uenced
by a role for this molecule in cartilage function.
AB - Objective To assess if a coding variant in the gene encoding transient receptor potential cation channel, subfamily V, member 1 ( TRPV1 ) is associated with
genetic risk of painful knee osteoarthritis (OA).
Methods The Ile585Val TRPV1 variant encoded by
rs8065080 was genotyped in 3270 cases of symptomatic
knee OA, 1098 cases of asymptomatic knee OA and
3852 controls from seven cohorts from the UK, the USA
and Australia. The genetic association between the
low-pain genotype Ilea??Ile and risk of symptomatic and
asymptomatic knee OA was assessed.
Results The TRPV1 585 Ilea??Ile genotype, reported to
be associated with lower thermal pain sensitivity, was
associated with a lower risk of symptomatic knee OA
in a comparison of symptomatic cases with healthy
controls, with an odds ratio (OR) of 0.75 (95 CI 0.64
to 0.88; p=0.00039 by meta-analysis) after adjustment
for age, sex and body mass index. No difference was
seen between asymptomatic OA cases and controls
(OR=1.02, 95 CI 0.82 to 1.27 p=0.86) but the Ilea??Ile
genotype was associated with lower risk of symptomatic
versus asymptomatic knee OA adjusting for covariates
and radiographic severity (OR=0.73, 95 CI 0.57 to 0.94
p=0.0136). TRPV1 expression in articular cartilage was
increased by infl ammatory cytokines (tumour necrosis
factor I? and interleukin 1). However, there were no
differences in TRPV1 expression in healthy and arthritic
synovial tissue.
Conclusions A genotype involved in lower peripheral
pain sensitivity is signifi cantly associated with a
decreased risk of painful knee OA. This indicates a role for
the pro-nociceptive gene TRPV1 in genetic susceptibility
to symptomatic knee OA, which may also be infl uenced
by a role for this molecule in cartilage function.
UR - http://ard.bmj.com/content/early/2011/05/25/ard.2010.148122.full.pdf+html
U2 - 10.1136/ard.2010.148122
DO - 10.1136/ard.2010.148122
M3 - Article
SN - 0003-4967
VL - 70
SP - 1556
EP - 1561
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 9
ER -